All Articles

Malnutrition in MASLD-related hepatocellular carcinoma: assessment limitations, multidimensional mechanisms, and microbiome-based interventions

Synergistic era: practice and reflection on TACE combined with systemic therapy in hepatocellular carcinoma

Multidisciplinary management of HCC

From algorithm to dialogue: interpreting the 2026 BCLC-CUSE strategy for HCC care

Precision medicine in metabolic dysfunction-associated steatotic liver disease: genetics, epigenetics, and emerging therapies

Incretin-based therapies in MASLD/MASH: from GLP-1 receptor agonists to dual and triple agonists - mechanisms, clinical evidence, and therapeutic perspectives

Global burden of liver cancer mortality due to alcohol use from 1990 to 2021 and predictions to 2050

Gut microbiota as predictors of immunotherapy response in hepatocellular carcinoma

Hepatocellular carcinoma tumor immune microenvironment: heterogeneity and therapeutic strategies

A review on decellularization scaffolding for liver regeneration in transplantation

A systematic review of comparative economic analyses of systemic therapies for hepatocellular carcinoma

Regional dietary patterns and risk of primary liver cancer in anhui, china: a population-based case-control study

Targeting gut microbiota to overcome immunotherapy resistance in hepatocellular carcinoma: from mechanisms to clinical practice

Helicobacter pylori is associated with a higher risk of MAFLD prevalence and all-cause mortality: results from the NHANES III follow-up study

An activated CD8⁺ T cell-based signature stratifies prognosis and suggests differential sensitivity to immune checkpoint inhibitors in hepatocellular carcinoma

Incretin-based therapies: a new era in metabolic liver disease management

Impact of metabolic reprogramming on the immune response in hepatocellular carcinoma

Yttrium-90 combination therapies in hepatocellular carcinoma: current evidence and future directions